» Articles » PMID: 16078219

Effect of Levodopa on Pain Threshold in Parkinson's Disease: a Clinical and Positron Emission Tomography Study

Overview
Journal Mov Disord
Date 2005 Aug 4
PMID 16078219
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Patients suffering from Parkinson's disease (PD) frequently experienced painful sensations that could be in part due to central modification of nociception. We compared pain threshold before and after administration of levodopa in PD patients and in controls, and investigated cerebral activity with positron emission tomography (PET) during experimental nociceptive stimulation. Pain threshold was determined using thermal stimulation during two randomized conditions: off and on. We performed H(2) (15)O PET analysis of regional cerebral blood flow on subjects while they received alternate randomized noxious and innocuous stimuli during off and on conditions. In off condition, pain threshold in nine PD patients was significantly lower than in nine controls. Administration of levodopa significantly raised pain threshold in PD patients but not in controls. During off condition, there was a significant increase in pain-induced activation in right insula and prefrontal and left anterior cingulate cortices in PD compared to control group. Levodopa significantly reduced pain-induced activation in these areas in PD. This study shows that pain threshold is lower in PD patients but returns to normal ranges after levodopa administration. Moreover, PD patients have higher pain-induced activation in nociceptive pathways, which can be reduced by levodopa.

Citing Articles

Brainstem serotonin amplifies nociceptive transmission in a mouse model of Parkinson's disease.

Grivet Z, Aby F, Verboven A, Bouali-Benazzouz R, Sueur B, Maingret F NPJ Parkinsons Dis. 2025; 11(1):11.

PMID: 39774033 PMC: 11706991. DOI: 10.1038/s41531-024-00857-1.


Pain in Parkinson's disease: a neuroanatomy-based approach.

Nardelli D, Gambioli F, De Bartolo M, Mancinelli R, Biagioni F, Carotti S Brain Commun. 2024; 6(4):fcae210.

PMID: 39130512 PMC: 11311710. DOI: 10.1093/braincomms/fcae210.


Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson's disease.

Mancini M, Calculli A, Di Martino D, Pisani A J Anesth Analg Crit Care. 2024; 4(1):33.

PMID: 38745258 PMC: 11094869. DOI: 10.1186/s44158-024-00169-z.


Dysregulated neuromodulation in the anterior cingulate cortex in chronic pain.

Lancon K, Seguela P Front Pharmacol. 2023; 14:1289218.

PMID: 37954846 PMC: 10634228. DOI: 10.3389/fphar.2023.1289218.


Altered parabrachial nucleus nociceptive processing may underlie central pain in Parkinson's disease.

Pautrat A, Tannir R, Pernet-Gallay K, Soutrenon R, Vendramini E, Sinniger V NPJ Parkinsons Dis. 2023; 9(1):78.

PMID: 37236965 PMC: 10220088. DOI: 10.1038/s41531-023-00516-x.